Skip to content

Clinical trials

Phase 4 Hypertension trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 4 Country / region: Germany Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20032
20045
20052
20064
20071
20081
20093
20101
20122

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim6
Novartis6
Bristol-Myers Squibb2
Takeda2
Charite University, Berlin, Germany1
Hannover Medical School1
Institut für Pharmakologie und Präventive Medizin1
Johannes Gutenberg University Mainz1
Novartis Pharmaceuticals1
RWTH Aachen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension25
Coronary Artery Disease3
Diabetes Mellitus, Type 22
Albuminuria1
Cardiovascular Diseases1
Diabetic Nephropathies1
Essential Hypertension1
Familial Primary Pulmonary Hypertension1
Insulin Resistance1
Metabolic Syndrome1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.